Regulatory science

Fragrance Creators Names Darci Ferrer as New Director, Regulatory Science

Retrieved on: 
Thursday, March 26, 2020
Regulatory science, Risk analysis, Regulatory affairs, Academic disciplines, Articles, Human activities

WASHINGTON, March 26, 2020 /PRNewswire/ -- Fragrance Creators Association announced Darci Ferrer as its new Director, Regulatory Science.

Key Points: 
  • WASHINGTON, March 26, 2020 /PRNewswire/ -- Fragrance Creators Association announced Darci Ferrer as its new Director, Regulatory Science.
  • Ferrer will oversee the association's efforts in science policy and regulatory affairs, working to ensure its positions are firmly grounded in sound science.
  • She joins the Fragrance Creators Association from the science and engineering firm, Exponent, where she was a regulatory scientist.
  • In her role as Director, Regulatory Science, she will oversee the association's Regulatory Science Executive Committee.

African Pharmaceutical Regulatory Affairs 2 Day Event (London, United Kingdom - March 23-24, 2020) - Explore the Harmonisation and Cooperation Initiatives in Africa - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 4, 2020
Health, Pharmaceutical, Pharmaceuticals policy, Articles, Regulatory agency, Regulatory compliance, Marketing authorization, Regulatory affairs, Health, Human activities, Regulatory science

The "Pharmaceutical Regulatory Affairs in Africa" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Regulatory Affairs in Africa" conference has been added to ResearchAndMarkets.com's offering.
  • This event will explore the key areas of African regulatory affairs, including the new SAHPRA guidelines in South Africa, and will focus on practical aspects to assist with your regulatory activities.
  • There are a number of distinct markets within the region, each with its own economic and regulatory characteristics.
  • This event will be of particular interest to all those who need to learn about successful marketing authorisation applications and regulatory compliance in key African areas.

Regulatory Affairs for Pharmaceutical Support Staff: Overview of EU Regulatory (Regulations, Directives and Guidelines) Procedures - London, United Kingdom - September 23-24, 2019

Retrieved on: 
Thursday, June 6, 2019
Occupations, Regulatory affairs, Regulatory science

DUBLIN, June 6, 2019 /PRNewswire/ -- The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 6, 2019 /PRNewswire/ -- The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.
  • This two-day course provides an introduction to pharmaceutical regulatory affairs and the basics of drug development and has been designed specifically for those working in a support staff role.
  • The course will provide a thorough grounding in the subject of regulatory affairs and enable you to perform in your role more effectively.
  • It is also suitable for those who interface with the regulatory affairs function and who provide support to the regulatory procedures and activities.

Two Day UK Seminar: Pharmaceutical Regulatory Affairs for Support Staff - Gain an Overview of EU Regulatory Procedures (London, United Kingdom - September 23-24, 2019)

Retrieved on: 
Monday, June 3, 2019
Occupations, Regulatory affairs, Articles, Health, Human activities, Clinical research, Pharmaceuticals policy, Regulatory science

DUBLIN, June 3, 2019 /PRNewswire/ -- The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 3, 2019 /PRNewswire/ -- The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.
  • This two day course provides an introduction to Pharmaceutical Regulatory Affairs and the basics of drug development and has been designed specifically for those working in a support staff role.
  • You will gain an overview of EU regulatory procedures required to register products in Europe and the regulatory activities that need to be complied with to keep products on the market.
  • It is also suitable for those who interface with the Regulatory Affairs function and who provide support to the Regulatory procedures and activities.

Two Day UK Course: Pharmaceutical Regulatory Affairs for Support Staff - London, United Kingdom - September 23-24, 2019 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 29, 2019
Health, Pharmaceutical, Professional services, Other Professional Services, Occupations, Regulatory affairs, Articles, Human activities, Health, Regulatory science

The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.
  • This two-day course provides an introduction to pharmaceutical regulatory affairs and the basics of drug development and has been designed specifically for those working in a support staff role.
  • The course will provide a thorough grounding in the subject of regulatory affairs and enable you to perform in your role more effectively.
  • It is also suitable for those who interface with the regulatory affairs function and who provide support to the regulatory procedures and activities.

22nd Century Group Hires Former Imperial Brands Head of Regulatory Science

Retrieved on: 
Wednesday, April 17, 2019
Health, Alternative medicine, Biotechnology, Natural Resources, Agriculture, Retail, Research, Tobacco, Science, Regulatory science, Risk analysis

Mr. Pritchard was formerly the Head of Regulatory Science for Imperial Brands, U.K. (LSE: IMB ).

Key Points: 
  • Mr. Pritchard was formerly the Head of Regulatory Science for Imperial Brands, U.K. (LSE: IMB ).
  • Mr. Pritchard will lead and oversee the global regulatory and compliance activities for 22nd Century Group.
  • As the head of Imperial Brands scientific regulatory engagement team, Mr. Pritchard led Imperials technical regulatory strategy and external scientific engagement on global product regulation.
  • John Pritchard is joining 22nd Century at a pivotal moment, explained Henry Sicignano, III, President and CEO of 22nd Century Group.

2-Day Course: EU Pharmaceutical Regulations & Strategy (London, United Kingdom - April 29-30, 2019) - ResearchAndMarkets.com

Retrieved on: 
Friday, February 22, 2019
Health, Pharmaceutical, Clinical research, Health, Occupations, Regulatory affairs, Articles, Pharmaceuticals policy, Pharmaceutical industry, Regulatory Flexibility Act, Regulatory science

The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering.
  • This course will provide an up-to date overview of the European pharmaceutical regulatory environment, procedures and obligations.
  • It will be of value for regulatory affairs personnel and also for those who interact with regulatory personnel in order to understand action timelines and information requirements.
  • This course is for you, particularly if involved in:

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Fourth Consecutive Year

Retrieved on: 
Tuesday, January 15, 2019
Technology, Software, Health, Biotechnology, Pharmaceutical, Research, FDA, Science, Health, Pharmaceutical industry, Drug discovery, Drug development, Food and Drug Administration, Regulatory science, Biotechnology

Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services.

Key Points: 
  • Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services.
  • Certaras scientists and technologies supported new treatments in a wide range of therapeutic areas, including oncology, respiratory, central nervous system, and rare diseases.
  • Our work, which integrates model-informed drug development, regulatory science and real-world evidence is leveraged to optimize decision-making.
  • https://www.fda.gov/NewsEvents/Speeches/ucm575400.htm
    Certara enables superior drug development and patient care decision-making through model-informed drug development, regulatory science, real-world evidence solutions and knowledge integration.